Atnaujinkite slapukų nuostatas

Lymphohaematopoietic Growth Factors in Cancer Therapy II Softcover reprint of the original 1st ed. 1992 [Minkštas viršelis]

  • Formatas: Paperback / softback, 123 pages, aukštis x plotis: 277x210 mm, weight: 350 g, 7 Illustrations, black and white; VII, 123 p. 7 illus., 1 Paperback / softback
  • Serija: ESO Monographs
  • Išleidimo metai: 16-Dec-2011
  • Leidėjas: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3642778038
  • ISBN-13: 9783642778032
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 123 pages, aukštis x plotis: 277x210 mm, weight: 350 g, 7 Illustrations, black and white; VII, 123 p. 7 illus., 1 Paperback / softback
  • Serija: ESO Monographs
  • Išleidimo metai: 16-Dec-2011
  • Leidėjas: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3642778038
  • ISBN-13: 9783642778032
Kitos knygos pagal šią temą:
Contents: Introduction and OverviewLymphopoietic Growth Factors: Pathophysiology of T-CellMediated Shock Induced by Bacterial Superantigens - NaturalKiller Cells and Interleukin-2-Activated Killer Cells -TumourImmunogenicity Induced by Exogenous Interleukins -Cytokine Gene Therapy of Cancer - Analysis of T-CellReceptor Variability in Tumour Infiltrating Lymphocytes -Clinical Studies with Interleukin-2: An Overview - ClinicalTrials with Local Administration of Lymphopoietic GrowthFactors - Clinical Trials with Interlaukin-2. The RomeExperience.Haematopoietic Growth Factors: Lymphohaematopoietic GrowthFactor Use in Lung Cancer Patients - Clinical Trials withHaematopoietic Growth Factors and Peripheral Blood StemCells

Daugiau informacijos

Springer Book Archives
and Overview.- Lymphopoietic Growth Factors.- Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience.- Haematopoietic Growth Factors.- Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells.